Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Polymeric nanocarriers are crucial in anticancer therapy.
• Polysaccharides, abundant natural polymers, offer biocompatibility, biodegradability, and low toxicity.
• Targeted drug delivery is essential to minimize systemic toxicity and maximize therapeutic effects in cancer treatment.

Purpose of the Study:

• To review the application of polysaccharide-based nanocarriers in cancer therapy.
• To highlight the advantages of polysaccharides in developing efficient drug delivery systems.
• To explore the role of polysaccharides in targeted delivery of anti-cancer agents.

Main Methods:

• Review of existing literature on polysaccharide structure and properties.
• Analysis of pharmaceutical applications of carbohydrate-based polymers in nanocarrier design.
• Discussion of polysaccharide-based nanosystems for targeted delivery, considering the enhanced permeation and retention (EPR) effect.

Main Results:

• Polysaccharides exhibit favorable properties for nanocarrier development, including ease of modification and low cost.
• Polysaccharide-based nanocarriers demonstrate potential for improved tumor localization and reduced systemic toxicity.
• Certain polysaccharides can act as targeting agents due to their selective cell affinity.

Conclusions:

• Polysaccharide-based nanocarriers are promising for delivering anti-cancer agents, including peptides, proteins, and nucleic acids.
• The unique properties of polysaccharides facilitate the design of effective and targeted cancer nanotherapeutics.
• Further research into polysaccharide co-polymers can advance drug delivery approaches in oncology.